Gerardo Turcatti, Benjamin Rappaz, Pierre Marquet
Compounds tested during drug development may have adverse effects on the heart; therefore all new chemical entities have to undergo extensive preclinical assessment for cardiac liability. Conventional intensity-based imaging techniques are not robust enoug ...
Optical Society of America2015